Aoxing Pharmaceutical Company, Inc.

CIK 1060426 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aoxing Pharmaceutical Company, Inc..

Recent SEC filings

FiledFormAccession number
Oct 17, 201715-12G0001096906-17-000675
Oct 6, 2017250001096906-17-000653
Oct 5, 2017EFFECT9999999995-17-002587
Sep 29, 2017AW0001096906-17-000636
Sep 28, 2017NT 10-K0001096906-17-000634
Sep 27, 2017POS AM0001096906-17-000632
Sep 26, 2017S-3/A0001096906-17-000618
Sep 25, 20178-K0001096906-17-000615
Aug 4, 20178-K0001096906-17-000499
Jun 22, 20178-K0001096906-17-000438
May 15, 201710-Q0001096906-17-000337
May 11, 2017DEF 14A0001654954-17-004387
May 11, 2017DEFA14A0001654954-17-004389
Feb 17, 201710-Q/A0001096906-17-000107
Feb 14, 201710-Q0001096906-17-000098
Nov 14, 201610-Q0001096906-16-002058
Oct 5, 201610-K0001096906-16-001934
Sep 28, 2016NT 10-K0001096906-16-001920
Jun 23, 20168-K0001096906-16-001710
May 16, 201610-Q0001096906-16-001598
May 3, 2016DEFA14A0001096906-16-001577
May 3, 2016DEF 14A0001096906-16-001575
Feb 8, 201610-Q0001096906-16-001361
Feb 1, 20168-K0001096906-16-001342
Jan 11, 20168-K0001096906-16-001320